NCT01796197 2026-02-05
Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCa
Dana-Farber Cancer Institute
Phase 2 Completed
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
Institut Bergonié
Dana-Farber Cancer Institute
University of Maryland, Baltimore
Medical College of Wisconsin
Albert Einstein College of Medicine
Amgen
Washington University School of Medicine